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Results: A total of 2595 amniocentesis were performed in our
hospital, and in 1837 (70.8%) the sole indication for a prenatal
invasive test was advanced maternal age. The mean maternal age in
the analyzed group was 37.3 years. There were 15 twin pregnancies.
In 5 cases, there were no cellular growth and the amniocentesis
wasn’t repeated. So, a total of 1847 cytogenetic results were
analyzed. A normal karyotype was indentified in 1790 (96.9%) and
in 57 (3.1%) the cytogenetic result was abnormal. Down syndrome
was the most common anomaly, identified in 33 cases (57.9%), one
of them being a mosaic trisomy. There were 2 cases of trisomy 18
(3.5%), 1 of trisomy 13 (1.8%). Turner syndrome was identified
in 2 cases (3.5%) and Klinefelter syndrome in 6 cases (10.5%).
In 8 of the abnormal cytogenetic results, there were structural
abnormalities. Regarding pregnancy outcomes, there were 21 cases
(1.1%) of abortion related to amniocentesis (within 15 days after the
invasive test), none of them having karyotype anomalies. Medical
interruption of pregnancy was performed in 45 cases (2.4%), 42 of
these because of karyotype anomalies.
Conclusions: Amniocentesis performed only because of advanced
maternal age allowed to identify 57 cases of abnormalities and
to offer the couple the informed decision about the future of the
pregnancy. However there are other congenital abnormalities that
are impossible to diagnose by amniocentesis. The risk of pregnancy
loss after amniocentesis is in agreement with other studies.
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Objectives: To determine maternal morbidities in relation to
prenatal diagnosis of lethal fetal anomalies and termination of
pregnancy (TOP).
Materials: Twenty five patients with prenatal diagnosis of lethal
fetal anomalies in Hospital Tengku Ampuan Afzan, Kuantan,
Malaysia.
Methods: This was a retrospective review in Hospital Tengku
Ampuan Afzan, Kuantan, Malaysia in the year of 2011. All patients
diagnosed prenatally to carry lethal fetal anomalies was reviewed.
Data regarding maternal morbidities and outcome was collected
from patients’ case note in the hospital record office. Analysis was
done by using SPSS version 17.0.
Results: Twenty five pregnant patients were diagnosed with lethal
fetal anomalies via ultrasound with or without genetic study. The
patients’ mean age was 29.9±6.3 years old. The mean gestational
age at diagnosis of lethal fetal anomalies and at TOP or delivery
were 26.5±7.4 and 28.7±7.8 weeks respectively. The lethal fetal
anomalies included fetuses with multiple structural abnormalities
(40%), anencephaly or severe encephalocele (32%), non-immune
hydrops fetalis (16%) and syndromic fetuses (12%) i.e. Pentalogy
of Cantrell and Edward’s syndrome. Seven (28%) patients had early
counseling and TOP at the gestation of <22 weeks. Beyond 22 weeks
gestation, 8 (32%) patients had TOP and 10 (40%) patients had
spontaneous delivery. Twenty (80%) patients delivered or aborted
vaginally, 3 (12%) patients with assisted breech delivery, and 2 (8%)
patients with abdominal delivery.
The abdominal deliveries were for transverse lie in labour
and emergency hysterotomy for failed induction complicated by
hysterectomy due to intraoperative finding of ruptured uterus.
Overall, the associated adverse events included abnormal lie
during delivery (16%), symptomatic polyhydramnios requiring
amnioreduction (16%), post-partum haemorrhage (12%), retained
placenta (12%), blood transfusion (8%), uterine rupture (4%)
and endometritis (4%). Mean duration of hospital stay was
6.6±3.7 days.
Conclusions: Prenatal diagnosis and TOP at an early gestation may
reduce maternal morbidities and improve the outcome.
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Objectives: To assess the usefulness and reliability of foetal
magnetocardiography as a prenatal diagnostic or screening tool.
Materials: The study involved a review of the medical records
of cases where the women had delivered at Tsukuba University
Hospital during April 2008-March 2011 and which fulfilled any
of the following criteria: foetal arrhythmia, foetal congenital
heart defect, foetal growth restriction, maternal anti-SSA antibody,
diabetes mellitus, gestational diabetes mellitus, and monochorionic
twin pregnancy.
Methods: All the women had undergone foetal magnetocar-
diography, foetal ultrasonography, and cardiotocography. Twelve-
lead electrocardiograms were obtained for all the neonates
with arrhythmia, congenital heart defects, or maternal anti-SSA
antibody.
Results: The study included 168 women. Foetal arrhythmia was
observed in 15 cases; foetal congenital heart defect without
arrhythmia, 28 cases; other congenital anomalies, 44 cases;
foetal growth restriction, 15 cases; anti-SSA antibody, 14 cases;
diabetes mellitus, 23 cases; gestational diabetes mellitus, 23
cases; and monochorionic twin pregnancy, 6 cases. Foetal
magnetocardiography was safely performed on all the foetuses,
and the results were analysed in detail. None of the mothers
or foetuses developed any adverse effects. From the foetal
arrhythmia cases, supraventricular tachycardia was observed in 1
case, supraventricular premature contraction in 10, and ventricular
premature contraction in 4. Prenatal administration of digoxin
and sotarol was successfully used in a case where short RP’
supraventricular tachycardia (PR = 158msec, RP’ = 123msec)
was observed. The PR interval in cases where maternal anti-SSA
antibody was present ranged from 86 to 146ms with an average
value of 107.1ms (±14.4ms). Complete AV block was not observed
in any patient. The prenatal diagnoses of arrhythmia, congenital
heart defect, and maternal anti-SSA antibody were consistent with
the neonatal diagnoses.
Conclusions: Foetal magnetocardiography is useful and reliable
as a diagnostic or screening tool for foetal arrhythmia and other
congenital diseases.
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Objectives: To evaluate a possible association between fetal nuchal
translucency (NT) and the chromosomal abnormality 48,XXYY.
Materials: A 31-years old woman, primigravida, underwent to fetal
nuchal translucency evaluation through USG (ultrasonography) at
13w + 4d.
Methods: The ultrasonograohy showed a pathological value of
nuchal translucency (3.6mm; r.r < 2.6mm). A chorionic villus
sampling was performed in order to determine the fetal karyotype.
Results: The cytogenetic exam showed the presence of the
chromosomal abnormality 48,XXYY. Despite of the fethal karyotype,
the patient decided to continue the pregnancy. A genetic counseling
